Clinical Application of Cytokines in Cancer Immunotherapy

Overview

Journal Drug Des Devel Ther

Specialty Pharmacology

Date 2021 Jun 3

PMID 34079226

Citations 38

Authors

Yi Qiu

Mengxi Su

Leyi Liu

Yiqi Tang

Yuan Pan

Jianbo Sun

Affiliations

Soon will be listed here.

Abstract

Cytokines are key components of the immune system and play pivotal roles in anticancer immune response. Cytokines as either therapeutic agents or targets hold clinical promise for cancer precise treatment. Here, we provide an overview of the various roles of cytokines in the cancer immunity cycle, with a particular focus on the clinical researches of cytokine-based drugs in cancer therapy. We review 27 cytokines in 2630 cancer clinical trials registered with ClinicalTrials.gov that had completed recruitment up to January 2021 while summarizing important cases for each cytokine. We also discuss recent progress in methods for improving the delivery efficiency, stability, biocompatibility, and availability of cytokines in therapeutic applications.

Citing Articles

Combined delivery of IL12 and an IL18 mutant without IL18BP-binding activity by an adenoviral vector enhances tumor specific immunity.

Cheng Y, Luo R, Li E Sci Rep. 2025; 15(1):3563.

PMID: 39875404 PMC: 11775126. DOI: 10.1038/s41598-024-84693-6.

Advances in nucleic acid-based cancer vaccines.

Liao H, Liu S J Biomed Sci. 2025; 32(1):10.

PMID: 39833784 PMC: 11748563. DOI: 10.1186/s12929-024-01102-w.

The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives.

Ahuja S, Zaheer S Korean J Clin Oncol. 2025; 20(2):51-73.

PMID: 39778508 PMC: 11717579. DOI: 10.14216/kjco.24009.

Nanomedicine for cancer patient-centered care.

Sorrentino C, Ciummo S, Fieni C, Di Carlo E MedComm (2020). 2024; 5(11):e767.

PMID: 39434967 PMC: 11491554. DOI: 10.1002/mco2.767.

Local administration of mRNA encoding cytokine cocktail confers potent anti-tumor immunity.

Li Z, Ling Hu , Wang Y, Liu Q, Liu J, Long H Front Immunol. 2024; 15:1455019.

PMID: 39290693 PMC: 11406011. DOI: 10.3389/fimmu.2024.1455019.

References

Cantarelli C, Angeletti A, Cravedi P . Erythropoietin, a multifaceted protein with innate and adaptive immune modulatory activity. Am J Transplant. 2019; 19(9):2407-2414. PMC: 6711804. DOI: 10.1111/ajt.15369. View

Dunne J, Lynch S, OFarrelly C, Todryk S, Hegarty J, Feighery C . Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. J Immunol. 2001; 167(6):3129-38. DOI: 10.4049/jimmunol.167.6.3129. View

Demento S, Steenblock E, Fahmy T . Biomimetic approaches to modulating the T cell immune response with nano- and micro- particles. Annu Int Conf IEEE Eng Med Biol Soc. 2009; 2009:1161-6. DOI: 10.1109/IEMBS.2009.5332625. View

Xu Q, Guo L, Gu X, Zhang B, Hu X, Zhang J . Prevention of colorectal cancer liver metastasis by exploiting liver immunity via chitosan-TPP/nanoparticles formulated with IL-12. Biomaterials. 2012; 33(15):3909-18. DOI: 10.1016/j.biomaterials.2012.02.014. View

Rinderknecht E, HUMBEL R . Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain. Proc Natl Acad Sci U S A. 1976; 73(12):4379-81. PMC: 431462. DOI: 10.1073/pnas.73.12.4379. View

Chen F, Huang G, Huang H . Preparation and application of dextran and its derivatives as carriers. Int J Biol Macromol. 2019; 145:827-834. DOI: 10.1016/j.ijbiomac.2019.11.151. View

Hara K, Shirasuna K, Usui F, Karasawa T, Mizushina Y, Kimura H . Interferon-tau attenuates uptake of nanoparticles and secretion of interleukin-1β in macrophages. PLoS One. 2014; 9(12):e113974. PMC: 4259327. DOI: 10.1371/journal.pone.0113974. View

Curnis F, Fiocchi M, Sacchi A, Gori A, Gasparri A, Corti A . NGR-tagged nano-gold: A new CD13-selective carrier for cytokine delivery to tumors. Nano Res. 2016; 9(5):1393-1408. PMC: 4876925. DOI: 10.1007/s12274-016-1035-8. View

Grabstein K, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V . Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science. 1994; 264(5161):965-8. DOI: 10.1126/science.8178155. View

10.

Armelin H . Pituitary extracts and steroid hormones in the control of 3T3 cell growth. Proc Natl Acad Sci U S A. 1973; 70(9):2702-6. PMC: 427087. DOI: 10.1073/pnas.70.9.2702. View

11.

Ye H, Tong J, Wu J, Xu X, Wu S, Tan B . Preclinical evaluation of recombinant human IFNα2b-containing magnetoliposomes for treating hepatocellular carcinoma. Int J Nanomedicine. 2014; 9:4533-50. PMC: 4184408. DOI: 10.2147/IJN.S67228. View

12.

Sabel M, Su G, Griffith K, Chang A . Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-alpha in a model of metastatic breast cancer. Breast Cancer Res Treat. 2009; 122(2):325-36. DOI: 10.1007/s10549-009-0570-3. View

13.

Borden E . Interferons α and β in cancer: therapeutic opportunities from new insights. Nat Rev Drug Discov. 2019; 18(3):219-234. DOI: 10.1038/s41573-018-0011-2. View

14.

Mocellin S, Marincola F, Young H . Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol. 2005; 78(5):1043-51. DOI: 10.1189/jlb.0705358. View

15.

Brzoska K, Gradzka I, Kruszewski M . Impact of silver, gold, and iron oxide nanoparticles on cellular response to tumor necrosis factor. Toxicol Appl Pharmacol. 2018; 356:140-150. DOI: 10.1016/j.taap.2018.08.005. View

16.

Hu B, Du H, Yan G, Zhuo R, Wu Y, Fan C . Magnetic polycarbonate microspheres for tumor-targeted delivery of tumor necrosis factor. Drug Deliv. 2013; 21(3):204-12. DOI: 10.3109/10717544.2013.843609. View

17.

Frederiksen K, Lundsgaard D, Freeman J, Hughes S, Holm T, Skrumsager B . IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinoma. Cancer Immunol Immunother. 2008; 57(10):1439-49. PMC: 2491425. DOI: 10.1007/s00262-008-0479-4. View

18.

Joshi B, Leland P, Asher A, Prayson R, Varricchio F, Puri R . In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures. Cancer Res. 2001; 61(22):8058-61. View

19.

CARSWELL E, Old L, Kassel R, Green S, Fiore N, Williamson B . An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975; 72(9):3666-70. PMC: 433057. DOI: 10.1073/pnas.72.9.3666. View

20.

Liu X, Gao X, Zheng S, Wang B, Li Y, Zhao C . Modified nanoparticle mediated IL-12 immunogene therapy for colon cancer. Nanomedicine. 2017; 13(6):1993-2004. DOI: 10.1016/j.nano.2017.04.006. View